We are conducting a novel biomarer driven Phase II clinical trial for recurrent high-grade gliomas using a retroviral gene therapy (DB107) and DB107-FC.

Phase 1 clinical trial for unresectable glioblastoma using Laser Ablation and synergistic anti-retroviral therapy

Our Multidisciplinary team offers a variety of tailored clinical trials using multimodal approaches including immunotherapy, targeted inhibitors, and radiation.

We are enrolling patients with newly diagnosed high grade gliomas to receive retroviral gene therapy plus radiation with or without chemotherapy. We are the only center in the region offering this trial for newly diagnosed brain tumors.